DENTSPLY SIRONA Inc. $XRAY Stock Position Lowered by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al lowered its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 36.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 143,600 shares of the medical instruments supplier’s stock after selling 82,100 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al owned approximately 0.07% of DENTSPLY SIRONA worth $1,272,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in XRAY. Paradigm Capital Management Inc. NY purchased a new position in shares of DENTSPLY SIRONA during the second quarter worth about $39,775,000. BlackRock Inc. acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at about $283,405,000. The Manufacturers Life Insurance Company purchased a new stake in DENTSPLY SIRONA during the 2nd quarter valued at approximately $1,956,000. Bank of New York Mellon Corp purchased a new stake in DENTSPLY SIRONA during the 2nd quarter valued at approximately $16,408,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $47,780,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Trading Up 9.5%

NASDAQ XRAY opened at $10.65 on Thursday. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The stock has a market capitalization of $2.12 billion, a P/E ratio of 6.80, a P/E/G ratio of 1.25 and a beta of 0.87. DENTSPLY SIRONA Inc. has a 52-week low of $8.32 and a 52-week high of $14.76. The firm has a 50-day moving average price of $9.65 and a 200 day moving average price of $11.30.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. The company had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. During the same quarter in the previous year, the company earned $0.52 EPS. The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on XRAY shares. BMO Capital Markets lowered their target price on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research note on Thursday, September 17th. Piper Sandler dropped their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Mizuho cut their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Thursday, October 22nd. Barrington Research decreased their price target on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, October 26th. Finally, Barclays lifted their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $12.62.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.